Renslow D Sherer

Summary

Affiliation: Project HOPE
Country: USA

Publications

  1. ncbi Microeconomic loans and health education to families in impoverished communities: implications for the HIV pandemic
    Renslow D Sherer
    The University of Chicago, Illinois, USA
    J Int Assoc Physicians AIDS Care (Chic) 3:110-4. 2004
  2. ncbi Rapid antiretroviral therapy scale-up in Hubei Province, China
    Renslow Sherer
    Section of Infectious Diseases, University of Chicago, USA
    Health Aff (Millwood) 27:1140-7. 2008
  3. ncbi The importance of potency and durability in HIV patient antiretroviral therapy preferences: a telephone survey
    Renslow D Sherer
    University of Chicago Hospitals, HIV TB STI Project HOPE, 5841 South Maryland Avenue, MC 5065, Chicago, IL 60637, USA
    AIDS Patient Care STDS 19:794-802. 2005

Detail Information

Publications3

  1. ncbi Microeconomic loans and health education to families in impoverished communities: implications for the HIV pandemic
    Renslow D Sherer
    The University of Chicago, Illinois, USA
    J Int Assoc Physicians AIDS Care (Chic) 3:110-4. 2004
    ..Because of the unique combination of increased household economic stability and improved health knowledge, the VHB program is now being adapted to families of people affected by HIV/AIDS, including orphans...
  2. ncbi Rapid antiretroviral therapy scale-up in Hubei Province, China
    Renslow Sherer
    Section of Infectious Diseases, University of Chicago, USA
    Health Aff (Millwood) 27:1140-7. 2008
    ..8 percent. This international partnership created a sustainable capacity for effective HIV prevention and care that could be replicable in other settings...
  3. ncbi The importance of potency and durability in HIV patient antiretroviral therapy preferences: a telephone survey
    Renslow D Sherer
    University of Chicago Hospitals, HIV TB STI Project HOPE, 5841 South Maryland Avenue, MC 5065, Chicago, IL 60637, USA
    AIDS Patient Care STDS 19:794-802. 2005
    ..These results, in conjunction with other studies, suggest that patients prioritize viral suppression, immune improvement, and regimen durability more highly than regimen convenience...